Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort.

Yang, Jing; Meng, Ling; Yang, Yongxin; Gao, Hongwei; Jiang, Honggang

Yang, Jing; Meng, Ling; Yang, Yongxin; Gao, Hongwei; Jiang, Honggang.

Afiliação

Yang J; Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Meng L; Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Yang Y; Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Gao H; Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Jiang H; Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China.

Nucleosides Nucleotides Nucleic Acids ; 43(3): 230-248, 2024.

Article em En | MEDLINE | ID: mdl-37688463

Assuntos

Mieloma Múltiplo; Receptor de Morte Celular Programada 1; Humanos; Receptor de Morte Celular Programada 1/genética; Mieloma Múltiplo/genética; Antígeno B7-H1/genética; Antígeno B7-H1/metabolismo; Linfócitos T CD8-Positivos/metabolismo; Estudos de Casos e Controles; Ligantes; China

Palavras-chave

Chinese; Multiple myeloma; PD-1; PDL-1; flow cytometry; gene polymorphism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Mieloma Múltiplo Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google